您的当前位置：首页 > 行业数据 > 图表17肿瘤免疫疗法中国市场销售规模

图表17肿瘤免疫疗法中国市场销售规模

市场规模

下载图片

原图定位

同报告图片

/ 4

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

所属报告：

动脉智库：2026肿瘤免疫疗法报告：超万条管线激战双抗爆发增长10大高价值疗法定义下一代创新（63页）.pdf

打包全文图表

PD-1抑制剂中国年销售规模超百亿，贡献肿瘤免疫疗法赛道主要营收。PD-1抑制剂是肿瘤免疫领域商业化最成功的产品品类，年销售额突破百亿人民币，市场抗注射液销售额达39.71亿人民币，百济神州的替雷利珠单抗注射液销售额为 35.63亿人民币。适应症拓展、医保政策支持、临床联合用药趋势，持续为PD-1 抑制剂市场提供增长动力。免疫检查点抑制剂双抗成为新一代销售增长主力，上市后销售额快速攀升。作为肿瘤免疫领域的创新品类，免疫检查点抑制剂双抗凭借突出的临床价值，获批上市后迅速打开市场，销售额呈现高速增长态势，2025年卡度尼利单抗注射液、依沃西单抗注射液、艾帕洛利托沃瑞利单抗注射液在中国市场的销售额分别达到 4.71亿、3.21亿、1.56亿人民币，同比增长 26.79%、6639.49%、290769.77%。商保覆盖将成为CAR-T疗法和TCE疗法销售额提升的核心推手。目前CAR-T 与TCE疗法的市场销售额处于亿元级别，尚未实现规模化放量，随着两类疗法进入商业健康保险的创新药目录，患者用药支付压力得到缓解，将推动市场销售额的稳步增长。临床局限性与支付模式制约了溶瘤病毒疗法的商业价值。国内溶瘤病毒赛道目前仅有安柯瑞1款产品上市，上市时间已超20年，近两年销量呈下滑趋势，一方面是支付端缺乏医保支持，患者需全额自费，一个完整疗程费用约在2.8万-4.2 万元；另一方面是给药方式受限，药物需直接注射至肿瘤部位，不适用于肺、肝较弱，获批适应症范围较窄。随着CRISPR基因编辑、静脉注射等新技术逐步应用于溶瘤病毒疗法研发，病毒量产纯化技术的进步，以及溶瘤病毒与PD-1抑制剂等药物联用治疗方案的临床探索，将从技术、疗效、应用场景多维度破解现存销售瓶颈。

市场规模原图定位